Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts. Show more
Location: 930 Winter Street, Waltham, MA, 02451, United States | Website: https://www.aerovatetx.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
77.68M
52 Wk Range
$2.63 - $884.98
Previous Close
$9.85
Open
$9.72
Volume
484,535
Day Range
$9.52 - $9.96
Enterprise Value
1.782M
Cash
76.21M
Avg Qtr Burn
-12.48M
Insider Ownership
0.02%
Institutional Own.
-
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date | 
|---|---|---|
| AV-101 Details  Pulmonary arterial hypertension | Phase 2/3 Update | 
